BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Division of Biology &amp; Biomedical Sciences//NONSGML Events//EN
CALSCALE:GREGORIAN
X-ORIGINAL-URL:https://dbbs.wustl.edu/calendar/
X-WR-CALDESC:Division of Biology &amp; Biomedical Sciences - Events
BEGIN:VEVENT
UID:20240705T1341Z-1720186881.4901-EO-14443-1@172.23.128.18
STATUS:CONFIRMED
DTSTAMP:20260715T121815Z
CREATED:20240705T134043Z
LAST-MODIFIED:20240705T134043Z
DTSTART;TZID=America/Chicago:20240725T130000
DTEND;TZID=America/Chicago:20240725T150000
SUMMARY: Speaker: Samuel Ameh – “Cellular and molecular basis of CD4+ T cel
 l help at the effector phase during immunotherapy of MHC-II negative tumors
 ””Cellular and molecular basis of CD4+ T cell help at the effector phase du
 ring immunotherapy of MHC-II negative tumors”
DESCRIPTION: PhD Thesis Examination Program in Immunology Laboratory of Dr.
  Robert Schreiber Department of Pathology and Immunology
X-ALT-DESC;FMTTYPE=text/html: <p><span data-contrast="none">PhD Thesis Exam
 ination</span></p><p>Program in Immunology</p><p>Laboratory of Dr. Robert S
 chreiber</p><p>Department of Pathology and Immunology</p>
CATEGORIES:DBBS Thesis Examination
LOCATION:Farrell Learning and Teaching Center\, Holden Auditorium
GEO:0;0
ORGANIZER;CN="Anthony":MAILTO:privitor@wustl.edu
URL;VALUE=URI:https://dbbs.wustl.edu/events/event/speaker-samuel-ameh-cellu
 lar-and-molecular-basis-of-cd4-t-cell-help-at-the-effector-phase-during-imm
 unotherapy-of-mhc-ii-negative-tumorscellular-and-molecular-basis-of-cd4-t-c
 ell-help-at-th/
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
DTSTART:20240310T080000
TZNAME:CDT
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR
